News
Climate change is creating new pathways for the spread of infectious diseases like brucellosis, tularemia, or E. coli in the ...
Officials have warned that the massive global animal trade could cause more potentially deadly diseases already circulating ...
Nearly one million people worldwide are plagued annually by cutaneous leishmaniasis, a devastating skin infection caused by ...
The world’s top health experts are raising the alarm about the risk of fur farms, wet markets, and illegal wildlife trade as ...
Since the pandemic, we are very aware of the power of social distancing to protect against infectious disease. But can social distancing be effective ...
Researchers have engineered Lyme bacterial protein, CspZ, to produce a robust immune response in mice for vaccine development.
After decades of trial and error, a promising new target for Lyme disease vaccine is emerging—the Lyme bacterial protein CspZ, which the bacteria use to evade detection from the body’s immune system.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results